Sangamo Therapeutics
SGMO
#10549
Rank
C$43.93 M
Marketcap
C$0.11
Share price
0.00%
Change (1 day)
-80.63%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2026 (TTM): C-$0.52

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$0.54. In 2025 the company made an earnings per share (EPS) of C-$0.63 an increase over its 2024 EPS that were of C-$0.73.

EPS history for Sangamo Therapeutics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.52-16.93%
2025C-$0.63-13.73%
2024C-$0.73
2022C-$1.790.81%
2021C-$1.7833.33%
2020C-$1.336.9%
2019C-$1.2522.54%
2018C-$1.021.43%
2017C-$1.00-31.37%
2016C-$1.4675.86%
2015C-$0.8348.72%
2014C-$0.56-17.02%
2013C-$0.679.3%
2012C-$0.62-39.44%
2011C-$1.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.57-1,857.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$24.91-4,673.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$3.38-721.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
C-$1.82 234.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C-$4.44 715.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.42-361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$28.39-5,313.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C-$0.13-76.32%๐Ÿ‡บ๐Ÿ‡ธ USA